1 HER2 Antibody Market Overview 1.1 Product Overview and Scope of HER2 Antibody 1.2 HER2 Antibody Segment by Type 1.2.1 Global HER2 Antibody Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Trastuzumab 1.2.3 Lapatinib 1.2.4 Ado-trastuzumab Emtansine 1.2.5 Pertuzumab 1.2.6 Everolimus 1.3 HER2 Antibody Segment by Application 1.3.1 HER2 Antibody Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital 1.3.3 Medical Center 1.4 Global HER2 Antibody Market Size Estimates and Forecasts 1.4.1 Global HER2 Antibody Revenue 2015-2026 1.4.2 Global HER2 Antibody Sales 2015-2026 1.4.3 HER2 Antibody Market Size by Region: 2020 Versus 2026 1.5 HER2 Antibody Industry 1.6 HER2 Antibody Market Trends 2 Global HER2 Antibody Market Competition by Manufacturers 2.1 Global HER2 Antibody Sales Market Share by Manufacturers (2015-2020) 2.2 Global HER2 Antibody Revenue Share by Manufacturers (2015-2020) 2.3 Global HER2 Antibody Average Price by Manufacturers (2015-2020) 2.4 Manufacturers HER2 Antibody Manufacturing Sites, Area Served, Product Type 2.5 HER2 Antibody Market Competitive Situation and Trends 2.5.1 HER2 Antibody Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key HER2 Antibody Players (Opinion Leaders) 3 HER2 Antibody Retrospective Market Scenario by Region 3.1 Global HER2 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global HER2 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America HER2 Antibody Market Facts & Figures by Country 3.3.1 North America HER2 Antibody Sales by Country 3.3.2 North America HER2 Antibody Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe HER2 Antibody Market Facts & Figures by Country 3.4.1 Europe HER2 Antibody Sales by Country 3.4.2 Europe HER2 Antibody Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific HER2 Antibody Market Facts & Figures by Region 3.5.1 Asia Pacific HER2 Antibody Sales by Region 3.5.2 Asia Pacific HER2 Antibody Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America HER2 Antibody Market Facts & Figures by Country 3.6.1 Latin America HER2 Antibody Sales by Country 3.6.2 Latin America HER2 Antibody Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa HER2 Antibody Market Facts & Figures by Country 3.7.1 Middle East and Africa HER2 Antibody Sales by Country 3.7.2 Middle East and Africa HER2 Antibody Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global HER2 Antibody Historic Market Analysis by Type 4.1 Global HER2 Antibody Sales Market Share by Type (2015-2020) 4.2 Global HER2 Antibody Revenue Market Share by Type (2015-2020) 4.3 Global HER2 Antibody Price Market Share by Type (2015-2020) 4.4 Global HER2 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global HER2 Antibody Historic Market Analysis by Application 5.1 Global HER2 Antibody Sales Market Share by Application (2015-2020) 5.2 Global HER2 Antibody Revenue Market Share by Application (2015-2020) 5.3 Global HER2 Antibody Price by Application (2015-2020) 6 Company Profiles and Key Figures in HER2 Antibody Business 6.1 Genentech Inc 6.1.1 Corporation Information 6.1.2 Genentech Inc Description, Business Overview and Total Revenue 6.1.3 Genentech Inc HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Genentech Inc Products Offered 6.1.5 Genentech Inc Recent Development 6.2 Novartis AG 6.2.1 Novartis AG Corporation Information 6.2.2 Novartis AG Description, Business Overview and Total Revenue 6.2.3 Novartis AG HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Novartis AG Products Offered 6.2.5 Novartis AG Recent Development 6.3 Pfizer 6.3.1 Pfizer Corporation Information 6.3.2 Pfizer Description, Business Overview and Total Revenue 6.3.3 Pfizer HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Pfizer Products Offered 6.3.5 Pfizer Recent Development 6.4 Abnova Corporation 6.4.1 Abnova Corporation Corporation Information 6.4.2 Abnova Corporation Description, Business Overview and Total Revenue 6.4.3 Abnova Corporation HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Abnova Corporation Products Offered 6.4.5 Abnova Corporation Recent Development 6.5 InvivoGen 6.5.1 InvivoGen Corporation Information 6.5.2 InvivoGen Description, Business Overview and Total Revenue 6.5.3 InvivoGen HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.5.4 InvivoGen Products Offered 6.5.5 InvivoGen Recent Development 6.6 Celltrion 6.6.1 Celltrion Corporation Information 6.6.2 Celltrion Description, Business Overview and Total Revenue 6.6.3 Celltrion HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Celltrion Products Offered 6.6.5 Celltrion Recent Development 6.7 Biocon Limited 6.6.1 Biocon Limited Corporation Information 6.6.2 Biocon Limited Description, Business Overview and Total Revenue 6.6.3 Biocon Limited HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Biocon Limited Products Offered 6.7.5 Biocon Limited Recent Development 6.8 Bio-Techne 6.8.1 Bio-Techne Corporation Information 6.8.2 Bio-Techne Description, Business Overview and Total Revenue 6.8.3 Bio-Techne HER2 Antibody Sales, Revenue and Gross Margin (2015-2020) 6.8.4 Bio-Techne Products Offered 6.8.5 Bio-Techne Recent Development 7 HER2 Antibody Manufacturing Cost Analysis 7.1 HER2 Antibody Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of HER2 Antibody 7.4 HER2 Antibody Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 HER2 Antibody Distributors List 8.3 HER2 Antibody Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global HER2 Antibody Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of HER2 Antibody by Type (2021-2026) 10.1.2 Global Forecasted Revenue of HER2 Antibody by Type (2021-2026) 10.2 HER2 Antibody Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of HER2 Antibody by Application (2021-2026) 10.2.2 Global Forecasted Revenue of HER2 Antibody by Application (2021-2026) 10.3 HER2 Antibody Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of HER2 Antibody by Region (2021-2026) 10.3.2 Global Forecasted Revenue of HER2 Antibody by Region (2021-2026) 10.4 North America HER2 Antibody Estimates and Projections (2021-2026) 10.5 Europe HER2 Antibody Estimates and Projections (2021-2026) 10.6 Asia Pacific HER2 Antibody Estimates and Projections (2021-2026) 10.7 Latin America HER2 Antibody Estimates and Projections (2021-2026) 10.8 Middle East and Africa HER2 Antibody Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global HER2 Antibody Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global HER2 Antibody Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global HER2 Antibody Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key HER2 Antibody Manufacturers Covered in This Study Table 5. Global HER2 Antibody Sales (K MT) by Manufacturers (2015-2020) Table 6. Global HER2 Antibody Sales Share by Manufacturers (2015-2020) Table 7. Global HER2 Antibody Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global HER2 Antibody Revenue Share by Manufacturers (2015-2020) Table 9. Global Market HER2 Antibody Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers HER2 Antibody Sales Sites and Area Served Table 11. Manufacturers HER2 Antibody Product Types Table 12. Global HER2 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global HER2 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibody as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key HER2 Antibody Players Table 16. Global HER2 Antibody Sales (K MT) by Region (2015-2020) Table 17. Global HER2 Antibody Sales Market Share by Region (2015-2020) Table 18. Global HER2 Antibody Revenue (Million US$) by Region (2015-2020) Table 19. Global HER2 Antibody Revenue Market Share by Region (2015-2020) Table 20. North America HER2 Antibody Sales by Country (2015-2020) (K MT) Table 21. North America HER2 Antibody Sales Market Share by Country (2015-2020) Table 22. North America HER2 Antibody Revenue by Country (2015-2020) (US$ Million) Table 23. North America HER2 Antibody Revenue Market Share by Country (2015-2020) Table 24. Europe HER2 Antibody Sales by Country (2015-2020) (K MT) Table 25. Europe HER2 Antibody Sales Market Share by Country (2015-2020) Table 26. Europe HER2 Antibody Revenue by Country (2015-2020) (US$ Million) Table 27. Europe HER2 Antibody Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific HER2 Antibody Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific HER2 Antibody Sales Market Share by Region (2015-2020) Table 30. Asia Pacific HER2 Antibody Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific HER2 Antibody Revenue Market Share by Region (2015-2020) Table 32. Latin America HER2 Antibody Sales by Country (2015-2020) (K MT) Table 33. Latin America HER2 Antibody Sales Market Share by Country (2015-2020) Table 34. Latin America HER2 Antibody Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America HER2 Antibody Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa HER2 Antibody Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa HER2 Antibody Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa HER2 Antibody Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa HER2 Antibody Revenue Market Share by Country (2015-2020) Table 40. Global HER2 Antibody Sales (K MT) by Type (2015-2020) Table 41. Global HER2 Antibody Sales Share by Type (2015-2020) Table 42. Global HER2 Antibody Revenue (Million US$) by Type (2015-2020) Table 43. Global HER2 Antibody Revenue Share by Type (2015-2020) Table 44. Global HER2 Antibody Price (USD/MT) by Type (2015-2020) Table 45. Global HER2 Antibody Sales (K MT) by Application (2015-2020) Table 46. Global HER2 Antibody Sales Market Share by Application (2015-2020) Table 47. Global HER2 Antibody Sales Growth Rate by Application (2015-2020) Table 48. Genentech Inc HER2 Antibody Corporation Information Table 49. Genentech Inc Description and Business Overview Table 50. Genentech Inc HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Genentech Inc Main Product Table 52. Genentech Inc Recent Development Table 53. Novartis AG HER2 Antibody Corporation Information Table 54. Novartis AG Corporation Information Table 55. Novartis AG HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Novartis AG Main Product Table 57. Novartis AG Recent Development Table 58. Pfizer HER2 Antibody Corporation Information Table 59. Pfizer Corporation Information Table 60. Pfizer HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Pfizer Main Product Table 62. Pfizer Recent Development Table 63. Abnova Corporation HER2 Antibody Corporation Information Table 64. Abnova Corporation Corporation Information Table 65. Abnova Corporation HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Abnova Corporation Main Product Table 67. Abnova Corporation Recent Development Table 68. InvivoGen HER2 Antibody Corporation Information Table 69. InvivoGen Corporation Information Table 70. InvivoGen HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. InvivoGen Main Product Table 72. InvivoGen Recent Development Table 73. Celltrion HER2 Antibody Corporation Information Table 74. Celltrion Corporation Information Table 75. Celltrion HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Celltrion Main Product Table 77. Celltrion Recent Development Table 78. Biocon Limited HER2 Antibody Corporation Information Table 79. Biocon Limited Corporation Information Table 80. Biocon Limited HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Biocon Limited Main Product Table 82. Biocon Limited Recent Development Table 83. Bio-Techne HER2 Antibody Corporation Information Table 84. Bio-Techne Corporation Information Table 85. Bio-Techne HER2 Antibody Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. Bio-Techne Main Product Table 87. Bio-Techne Recent Development Table 88. Sales Base and Market Concentration Rate of Raw Material Table 89. Key Suppliers of Raw Materials Table 90. HER2 Antibody Distributors List Table 91. HER2 Antibody Customers List Table 92. Market Key Trends Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 94. Key Challenges Table 95. Global HER2 Antibody Sales (K MT) Forecast by Type (2021-2026) Table 96. Global HER2 Antibody Sales Market Share Forecast by Type (2021-2026) Table 97. Global HER2 Antibody Revenue (Million US$) Forecast by Type (2021-2026) Table 98. Global HER2 Antibody Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 99. Global HER2 Antibody Sales (K MT) Forecast by Application (2021-2026) Table 100. Global HER2 Antibody Revenue (Million US$) Forecast by Application (2021-2026) Table 101. Global HER2 Antibody Sales (K MT) Forecast by Region (2021-2026) Table 102. Global HER2 Antibody Sales Market Share Forecast by Region (2021-2026) Table 103. Global HER2 Antibody Revenue Forecast by Region (2021-2026) (US$ Million) Table 104. Global HER2 Antibody Revenue Market Share Forecast by Region (2021-2026) Table 105. Research Programs/Design for This Report Table 106. Key Data Information from Secondary Sources Table 107. Key Data Information from Primary Sources List of Figures Figure 1. Picture of HER2 Antibody Figure 2. Global HER2 Antibody Sales Market Share by Type: 2020 VS 2026 Figure 3. Trastuzumab Product Picture Figure 4. Lapatinib Product Picture Figure 5. Ado-trastuzumab Emtansine Product Picture Figure 6. Pertuzumab Product Picture Figure 7. Everolimus Product Picture Figure 8. Global HER2 Antibody Consumption Market Share by Application: 2020 VS 2026 Figure 9. Hospital Figure 10. Medical Center Figure 11. Global HER2 Antibody Market Size 2015-2026 (US$ Million) Figure 12. Global HER2 Antibody Sales Capacity (K MT) (2015-2026) Figure 13. Global HER2 Antibody Market Size Market Share by Region: 2020 Versus 2026 Figure 14. HER2 Antibody Sales Share by Manufacturers in 2020 Figure 15. Global HER2 Antibody Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by HER2 Antibody Revenue in 2019 Figure 17. HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global HER2 Antibody Sales Market Share by Region (2015-2020) Figure 19. Global HER2 Antibody Sales Market Share by Region in 2019 Figure 20. Global HER2 Antibody Revenue Market Share by Region (2015-2020) Figure 21. Global HER2 Antibody Revenue Market Share by Region in 2019 Figure 22. North America HER2 Antibody Sales Market Share by Country in 2019 Figure 23. North America HER2 Antibody Revenue Market Share by Country in 2019 Figure 24. U.S. HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 25. U.S. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 27. Canada HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe HER2 Antibody Sales Market Share by Country in 2019 Figure 29. Europe HER2 Antibody Revenue Market Share by Country in 2019 Figure 30. Germany HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 31. Germany HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 33. France HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 35. U.K. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 37. Italy HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 39. Russia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific HER2 Antibody Sales Market Share by Region in 2019 Figure 41. Asia Pacific HER2 Antibody Revenue Market Share by Region in 2019 Figure 42. China HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 43. China HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 45. Japan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 47. South Korea HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 49. India HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 51. Australia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 53. Taiwan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 55. Indonesia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 57. Thailand HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 59. Malaysia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 61. Philippines HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 63. Vietnam HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America HER2 Antibody Sales Market Share by Country in 2019 Figure 65. Latin America HER2 Antibody Revenue Market Share by Country in 2019 Figure 66. Mexico HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 67. Mexico HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 69. Brazil HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 71. Argentina HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa HER2 Antibody Sales Market Share by Country in 2019 Figure 73. Middle East and Africa HER2 Antibody Revenue Market Share by Country in 2019 Figure 74. Turkey HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 75. Turkey HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 77. Saudi Arabia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E HER2 Antibody Sales Growth Rate (2015-2020) (K MT) Figure 79. U.A.E HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of HER2 Antibody by Type (2015-2020) Figure 81. Sales Market Share of HER2 Antibody by Type in 2019 Figure 82. Revenue Share of HER2 Antibody by Type (2015-2020) Figure 83. Revenue Market Share of HER2 Antibody by Type in 2019 Figure 84. Global HER2 Antibody Sales Growth by Type (2015-2020) (K MT) Figure 85. Global HER2 Antibody Sales Market Share by Application (2015-2020) Figure 86. Global HER2 Antibody Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of HER2 Antibody by Application (2015-2020) Figure 88. Global Revenue Share of HER2 Antibody by Application in 2020 Figure 89. Genentech Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. Price Trend of Key Raw Materials Figure 98. Manufacturing Cost Structure of HER2 Antibody Figure 99. Manufacturing Process Analysis of HER2 Antibody Figure 100. HER2 Antibody Industrial Chain Analysis Figure 101. Channels of Distribution Figure 102. Distributors Profiles Figure 103. Porter's Five Forces Analysis Figure 104. North America HER2 Antibody Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 105. North America HER2 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 106. Europe HER2 Antibody Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 107. Europe HER2 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Latin America HER2 Antibody Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. Latin America HER2 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Middle East and Africa HER2 Antibody Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. Middle East and Africa HER2 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Asia Pacific HER2 Antibody Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. Asia Pacific HER2 Antibody Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Bottom-up and Top-down Approaches for This Report Figure 115. Data Triangulation Figure 116. Key Executives Interviewed

Genentech Inc Novartis AG Pfizer Abnova Corporation InvivoGen Celltrion Biocon Limited Bio-Techne